You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Cost Effective Solar Array based on High Efficiency Thin-Film Technology

    SBC: COMPOSITE TECHNOLOGY DEVELOPMENT, INC.            Topic: AF13AT06

    ABSTRACT: This Phase I effort will involve the development of an ultra low cost, high specific power, modular and flexible solar array module using currently available thin-film solar cells, innovative interconnects, and flexible encapsulation. The high efficiency thin-film solar cells will enable high specific power and flexibility in the module. The interconnect scheme and encapsulation will a ...

    STTR Phase I 2014 Department of DefenseAir Force
  2. Secure Efficient Cross-domain Protocols

    SBC: SONALYSTS INC            Topic: AF13AT08

    ABSTRACT: The Sonalysts team proposes to develop a solution that facilitates the flow of data between different levels of classification while improving and ensuring both security and data integrity. Our approach involves a set of protocols that provide a unique and disruptive combination of multichannel data dispersion and multi-classification data management techniques to meet our objectives. ...

    STTR Phase I 2014 Department of DefenseAir Force
  3. Versatile and Robust Three-Dimensional Software for Multi-Fluid Plasma Modeling

    SBC: TECH-X CORPORATION            Topic: AF11BT08

    ABSTRACT: In this STTR Tech-X corporation in partnership with the University of Washington will improve a commercial plasma modeling tool, Nautilus, for simulating high-temperature multi-fluid plasmas for problems such as the field reversed configuration, dense plasma focus and the plasma opening switch. Semi-implicit algorithms will be implemented in Nautilus so that the speed of light and elec ...

    STTR Phase II 2014 Department of DefenseAir Force
  4. Satellite Drag Physical Model Module for a Near Real Time Operation Test Bed

    SBC: ATMOSPHERIC & SPACE TECHNOLOGY RESEARCH ASSOCIATES LLC            Topic: AF11BT29

    ABSTRACT: The Air Force seeks to improve the accuracy of orbit specification and of 72-h orbit predictions beyond present capabilities. Thermospheric neutral density and satellite ballistic coefficient strongly impact satellite drag estimation, which is a leading source of error in orbit predictions in LEO. The goal of this Phase II project is to develop a satellite drag specification capability ...

    STTR Phase II 2014 Department of DefenseAir Force
  5. Smartphone Help for DWI Offenders and Their Families: A B-SMART App

    SBC: KLEIN BUENDEL, INC.            Topic: NIAAA

    DESCRIPTION (provided by applicant): Driving while intoxicated (DWI) remains a substantial and preventable source of morbidity and mortality in the United States. A variety of sanctions and interventions have been attempted to reduce DWI in the U.S., including enhanced DWI enforcement efforts, stricter drunk driving laws, responsible alcohol beverage service training, and alcohol treatment. The Ig ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Removal of Amyloid-beta Peptides from the Alzheimer's Brain

    SBC: WE BIOSCIENCES, LLC            Topic: NIA

    DESCRIPTION (provided by applicant): As the Alzheimer's disease (AD) population is growing rapidly, currently there are no cure treatments. The goal of this resubmitted STTR proposal is to conduct a preclinical study with pramlintide to prove a potential treatment for AD. We have revised the proposal significantly according to the reviewers' comments. Pramlintide is an FDA approved drug ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Testing Smad7-based biologics for treating chronic wounds

    SBC: Taiga Biotechnologies, Inc.            Topic: NIAMS

    DESCRIPTION (provided by applicant): Chronic skin wounds associated with various diseases (e.g., diabetes) and aberrant healing from acute wounding (e.g., hypertrophic scarring) is a major health care burden, which need scientific discovery-based therapeutic interventions. Our previous studies show that Smad7, a TGFb signaling antagonist, accelerates skin wound healing. We have developed a Smad7 f ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Functional-selection of affinity reagents against DNA-protein complexes using targeted chromatin sequences

    SBC: AXIOMX INC            Topic: NIDDK

    DESCRIPTION (provided by applicant): Site-specific binding of proteins to DNA plays an important role in cell development, cell signaling, the cell cycle, and diseases such as cancer. There are two overarching goals to this proposal: (1) to develop a meansfor the identification of proteins bound to specific DNA sequences, and (2) to develop a better method for the identification of immunoprecipita ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Developing a new treatment for MS: Controlling CD40 in EAE

    SBC: Op-T-Mune, Inc            Topic: NIAID

    DESCRIPTION (provided by applicant): The National Multiple Sclerosis (MS) Society reports that 1.2 million people worldwide and more than 400,000 people in the U.S. have clinically diagnosed MS. Currently there are 10 FDA approved drugs for MS but none ofthe current drugs have impacted the course of MS to prevent relapses or progression of disease. An efficient means to control the autoimmune infl ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Measurement of Beta Cell Death in Diabetes

    SBC: L2 DIAGNOSTICS LLC            Topic: 200

    DESCRIPTION provided by applicant All forms of diabetes are characterized by the death of insulin producing cells In Type diabetes T D this leads to the reliance on exogenous insulin for survival Death of cells is silent it cannot be detected in vivo until it has progressed to such an extent that metabolic function is impaired The loss of cells has only been assessed by functiona ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government